SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 11th, 2022 • Trinity Biotech PLC • In vitro & in vivo diagnostic substances
NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, the Company and the Purchaser agree as follows:
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 11th, 2022 • Trinity Biotech PLC • In vitro & in vivo diagnostic substances • New York
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is entered into as of this ● day of April, 2022 by and among Trinity Biotech plc, a public limited company incorporated under the laws of Ireland (“Company”), and certain persons listed on Schedule A hereto (such persons, in their capacity as holders of Registrable Securities (as defined below), the “Holders” and each a “Holder”).
DATED APRIL [•], 2022Securities Purchase Agreement • April 11th, 2022 • Trinity Biotech PLC • In vitro & in vivo diagnostic substances
THIS REDEEMABLE UNSECURED CONVERTIBLE LOAN NOTE AND THE RIGHTS AND OBLIGATIONS EVIDENCED HEREBY ARE SUBORDINATE IN THE MANNER AND TO THE EXTENT SET FORTH IN THAT CERTAIN SUBORDINATION AGREEMENT (THE “SUBORDINATION AGREEMENT”) DATED AS OF APRIL 8, 2022 AMONG MICO IVD HOLDINGS LLC, A LIMITED LIABILITY COMPANY ORGANIZED UNDER THE LAWS OF THE STATE OF DELAWARE (“MICO”), AS SUBORDINATED LENDER AND PERCEPTIVE CREDIT HOLDINGS III, LP AS AGENT ON BEHALF OF SENIOR LENDERS (“SENIOR AGENT”), TO THE INDEBTEDNESS (INCLUDING INTEREST) OWED BY THE OBLIGORS PURSUANT TO THAT CERTAIN CREDIT AGREEMENT AND GUARANTY DATED AS OF DECEMBER 15, 2021 AMONG THE BORROWERS PARTY THERETO (“BORROWERS”), THE GUARANTORS FROM TIME TO TIME PARTY THERETO (“GUARANTORS” AND TOGETHER WITH THE BORROWERS, THE “OBLIGORS”), SENIOR AGENT AND THE LENDERS FROM TIME TO TIME PARTY THERETO, AS SUCH CREDIT AGREEMENT AND GUARANTY MAY BE AMENDED, SUPPLEMENTED OR OTHERWISE MODIFIED FROM TIME TO TIME AND TO INDEBTEDNESS REFINANCING THE IN
